Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Handoko

Showing results (391-400 of 414) with videos related to

Pageof 42
Sort By:
JAMA Network Open|March 7, 2024
Representation of Patients With Chronic Kidney Disease in Clinical Trials of Cardiovascular Disease Medications: A Systematic ReviewJulia M T Colombijn, Demy L Idema, Sanne van Beem, et al.
European Heart Journal. Digital Health|September 25, 2024
Design and rationale of the Engage-HF study: the impact of a gamified engagement toolkit on participation and engagement in a heart failure registryAbdul Shakoor, Chanu Mohansingh, Azzeddine El Osrouti, et al.
European Journal of Cardiovascular Nursing|April 8, 2026
The Impact of a Gamified Engagement Toolkit on Heart Failure Registry Participation: Results of the Engage-HF StudyAbdul Shakoor, Niels Scholte, Rik van de Kamp, et al.
Neurosurgery|January 13, 2023
Epilepsy Surgery in Young Children With Tuberous Sclerosis Complex: A Novel Hybrid Multimodal Surgical ApproachVijay M Ravindra, Patrick J Karas, Tyler T Lazaro, et al.
Circulation|November 24, 2017
Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial HypertensionDenielli da Silva Gonçalves Bós, Cathelijne E E Van Der Bruggen, Kondababu Kurakula, et al.
Journal for Immunotherapy of Cancer|April 24, 2024
Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockadeJason K Cullen, Pei-Yi Yap, Blake Ferguson, et al.
Microbiology Resource Announcements|April 18, 2020
Genome Sequences of 12 Phages That Infect Klebsiella pneumoniaeTrever L Thurgood, Ruchira Sharma, Jackson J Call, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2021
Targeting the P2Y<sub>13</sub> Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental AsthmaRhiannon B Werder, Md Ashik Ullah, Muhammed Mahfuzur Rahman, et al.
European Journal of Heart Failure|June 28, 2020
Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic reviewMichiel T H M Henkens, Sharon Remmelzwaal, Emma L Robinson, et al.
Nature Medicine|March 30, 2025
Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trialJob J Herrmann, Hans-Peter Brunner-La Rocca, Lisette E H J M Baltussen, et al.
Pageof 42

Showing results (391-400 of 414) with videos related to

Sort By:
Pageof 42
JAMA Network Open|March 7, 2024
Representation of Patients With Chronic Kidney Disease in Clinical Trials of Cardiovascular Disease Medications: A Systematic ReviewJulia M T Colombijn, Demy L Idema, Sanne van Beem, et al.
European Heart Journal. Digital Health|September 25, 2024
Design and rationale of the Engage-HF study: the impact of a gamified engagement toolkit on participation and engagement in a heart failure registryAbdul Shakoor, Chanu Mohansingh, Azzeddine El Osrouti, et al.
European Journal of Cardiovascular Nursing|April 8, 2026
The Impact of a Gamified Engagement Toolkit on Heart Failure Registry Participation: Results of the Engage-HF StudyAbdul Shakoor, Niels Scholte, Rik van de Kamp, et al.
Neurosurgery|January 13, 2023
Epilepsy Surgery in Young Children With Tuberous Sclerosis Complex: A Novel Hybrid Multimodal Surgical ApproachVijay M Ravindra, Patrick J Karas, Tyler T Lazaro, et al.
Circulation|November 24, 2017
Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial HypertensionDenielli da Silva Gonçalves Bós, Cathelijne E E Van Der Bruggen, Kondababu Kurakula, et al.
Journal for Immunotherapy of Cancer|April 24, 2024
Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockadeJason K Cullen, Pei-Yi Yap, Blake Ferguson, et al.
Microbiology Resource Announcements|April 18, 2020
Genome Sequences of 12 Phages That Infect Klebsiella pneumoniaeTrever L Thurgood, Ruchira Sharma, Jackson J Call, et al.
American Journal of Respiratory and Critical Care Medicine|December 3, 2021
Targeting the P2Y<sub>13</sub> Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental AsthmaRhiannon B Werder, Md Ashik Ullah, Muhammed Mahfuzur Rahman, et al.
European Journal of Heart Failure|June 28, 2020
Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic reviewMichiel T H M Henkens, Sharon Remmelzwaal, Emma L Robinson, et al.
Nature Medicine|March 30, 2025
Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trialJob J Herrmann, Hans-Peter Brunner-La Rocca, Lisette E H J M Baltussen, et al.
Pageof 42